ARCTURUS BIOSCIENCE, INC. – Trademark Portfolio
Entity Type: 03
ARCTURUS BIOSCIENCE, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CAPSURE, RIBOAMP, PARADISE, PICOPURE, and HISTOGENE. The owner is based in MOUNTAIN VIEW, CA.
400 LOGUE AVENUE
MOUNTAIN VIEW, CA 94043
Showing of trademarks Trademarks
Trademark Classifications
ARCTURUS BIOSCIENCE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does ARCTURUS BIOSCIENCE, INC. have?
ARCTURUS BIOSCIENCE, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 5 cancelled.
What trademark classes does ARCTURUS BIOSCIENCE, INC. file in?
ARCTURUS BIOSCIENCE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ARCTURUS BIOSCIENCE, INC.'s most well-known trademarks?
ARCTURUS BIOSCIENCE, INC.'s registered trademark portfolio includes well-known marks such as CAPSURE, RIBOAMP, PARADISE, PICOPURE, and HISTOGENE. These are among 5 currently registered trademarks in the portfolio.
What is ARCTURUS BIOSCIENCE, INC.'s trademark registration success rate?
ARCTURUS BIOSCIENCE, INC. has a 38% trademark registration rate, with 5 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.